カテゴリ： GlobalData, グローバル, 企業調査

Virginia Electric and Power Company：企業の発電所・SWOT分析2018

◆英語タイトル：Virginia Electric and Power Company - Power Plants and SWOT Analysis, 2018 Update
◆商品コード：DATA904C5889
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：57
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：グローバル
◆産業分野：電力
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD1,000 ⇒換算￥148,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD2,000 ⇒換算￥296,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD3,000 ⇒換算￥444,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Virginia Electric and Power Company – Power Plants and SWOT Analysis, 2018 Update
Summary

The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.

Scope

- Major Power Plants (assets) – summarized and detailed information about the power plants (assets).
- Operational Metrics (capacity, generation, revenue, sales, number of consumers).
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands
- Key employees – A list of the key executives and personnel heading key departments/functions.
- Executive biographies – A brief summary of the executives’ employment history.
- Financial deals – Coverage of key financial deals from 2006 onwards, depending upon information availability
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

* Note: Some sections may be missing if data is unavailable for the company.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
Company Snapshot 5
Key Information 5
Company Overview 5
SWOT Snapshot 5
Operational Metrics 6
Virginia Electric and Power Company, Operational Metrics, By Capacity 6
Virginia Electric and Power Company, Operational Metrics, By Transmission 6
Virginia Electric and Power Company, Operational Metrics, By Distribution 6
Virginia Electric and Power Company, Operational Metrics, By Segmental Information 6
Virginia Electric and Power Company, Operational Metrics, By Sales 7
Virginia Electric and Power Company, Wind Farms 8
Virginia Electric and Power Company, Wind Farms, United States 8
Virginia Electric and Power Company, Solar PV Parks 9
Virginia Electric and Power Company, Solar PV Parks, United States 9
Virginia Electric and Power Company, Hydro Power Plants 10
Virginia Electric and Power Company, Hydro Power Plants, United States 10
Virginia Electric and Power Company, Biopower Plants 11
Virginia Electric and Power Company, Biopower Plants, United States 11
Virginia Electric and Power Company, Thermal Power Plants 12
Virginia Electric and Power Company, Thermal Power Plants, United States 12
Virginia Electric and Power Company, Commercial Reactors 15
Virginia Electric and Power Company, Commercial Reactors, United States 15
Business Description 16
Business Overview 16
Corporate and Other 16
Overview 16
Power Delivery 16
Overview 16
Power Generation 16
Overview 16
Major Products and Services 17
History 18
SWOT Analysis 19
Overview 19
Virginia Electric and Power Company Strengths 19
Electricity Generation 19
Synergy with Parent Company 19
Energy Supply 19
Cost Efficiency 20
Virginia Electric and Power Company Weaknesses 20
Working Capital Deficit 20
Virginia Electric and Power Company Opportunities 20
Increase in Demand for Electricity: the US 20
SunShot Initiative: the US 20
Renewable Energy Initiatives: Virginia 20
Virginia Electric and Power Company Threats 20
Transmission and Distribution Network Safety 20
Environmental Laws and Regulations 21
Seasonal Variations and Climate Conditions 21
Key Employees 22
Key Employee Biographies 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Financial Deals Landscape 25
Virginia Electric and Power Company, Deals Summary 25
Virginia Electric and Power Company, Power, Deal Details 26
Asset Transactions 26
Dominion Virginia Invests USD1.1 Billion in Gas Fired Power Station in Virginia, US 26
Dominion Virginia Power To Invest US$2 Million In Gloucester Rooftop Solar Plant In US 27
Dominion Virginia Power To Invest US$0.5 Million In Old Dominion University Rooftop Solar Plant In Virginia, US 28
Dominion Virginia Acquires Azalea Solar Project From Smart Energy And Jacoby Development In Georgia, US 29
Dominion Virginia To Invest US$80 Million In Solar Power Project In Virginia, US 30
Dominion Virginia to Invest USD1.1 Billion in Warren County Natural Gas Fired Combined Cycle Power Project in Virginia, US 31
Debt Offering 32
Virginia Electric and Power Prices Public Offering of 3.8% Notes Due 2047 for USD550 Million 32
Virginia Electric and Power Prices Public Offering of 2.75% Notes Due 2023 for USD200 Million 33
Virginia Electric and Power Raises USD750 Million in Public Offering of 3.5% Notes Due 2027 34
Virginia Electric and Power Raises USD400 Million in Public Offering of Series B 2.95% Notes Due 2026 36
Virginia Electric and Power Raises USD500 Million in Public Offering of Series C 4% Notes Due 2046 38
Virginia Electric and Power Raises USD750 Million in Public Offering of 3.15% Notes Due 2026 for USD750 Million 40
Virginia Electric and Power Raises USD350 Million in Public Offering of 3.1% Notes Due 2025 42
Virginia Electric and Power Raises USD350 Million in Public Offering of 4.2% Notes Due 2045 44
Virginia Electric and Power Completes Public Offering Of 3.45% Notes Due 2024 For US$350 Million 46
Virginia Electric and Power Completes Public Offering Of 4.45% Notes Due 2044 For US$400 Million 48
Virginia Electric and Power Completes Public Offering Of Notes Due 2043 For US$585 Million 50
Virginia Electric and Power Completes Public Offering Of 2.75% Notes Due 2023 For US$500 Million 52
Virginia Electric and Power Completes Public Offering Of 1.2% Notes Due 2018 For US$250 Million 53
Virginia Electric and Power Completes Public Offering Of 4% Notes Due 2043 For US$500 Million 54
Virginia Electric and Power Completes Public Offering Of 2.95% Senior Notes Due 2022 For US$450 Million 55
Appendix 56
Report Scope 56
GlobalData Coverage 56
Benchmarking 56
GlobalData’s Methodology 56
Secondary Research 56
Primary Research 57
Contact Us 57
Disclaimer 57

List of Tables
Virginia Electric and Power Company, Key Facts 5
Virginia Electric and Power Company, Operational Metrics, Capacity 6
Virginia Electric and Power Company, Operational Metrics, Transmission 6
Virginia Electric and Power Company, Operational Metrics, Distribution 6
Virginia Electric and Power Company, Operational Metrics, Segmental Information 6
Virginia Electric and Power Company, Operational Metrics, Sales 7
Virginia Electric and Power Company, Wind Farms, United States 8
Virginia Electric and Power Company, Solar PV Parks, United States 9
Virginia Electric and Power Company, Hydro Power Plants, United States 10
Virginia Electric and Power Company, Biopower Plants, United States 11
Virginia Electric and Power Company, Thermal Power Plants, United States 12
Virginia Electric and Power Company, Commercial Reactors, United States 15
Major Products and Services 17
Virginia Electric and Power Company, SWOT Analysis 19
Virginia Electric and Power Company, Key Employees 22
Virginia Electric and Power Company, Subsidiaries 24
Virginia Electric and Power Company, Deals Summary 25
Dominion Virginia Invests USD1.1 Billion in Gas Fired Power Station in Virginia, US 26
Dominion Virginia Power To Invest US$2 Million In Gloucester Rooftop Solar Plant In US 27
Dominion Virginia Power To Invest US$0.5 Million In Old Dominion University Rooftop Solar Plant In Virginia, US 28
Dominion Virginia Acquires Azalea Solar Project From Smart Energy And Jacoby Development In Georgia, US 29
Dominion Virginia To Invest US$80 Million In Solar Power Project In Virginia, US 30
Dominion Virginia to Invest USD1.1 Billion in Warren County Natural Gas Fired Combined Cycle Power Project in Virginia, US 31
Virginia Electric and Power Prices Public Offering of 3.8% Notes Due 2047 for USD550 Million 32
Virginia Electric and Power Prices Public Offering of 2.75% Notes Due 2023 for USD200 Million 33
Virginia Electric and Power Raises USD750 Million in Public Offering of 3.5% Notes Due 2027 34
Virginia Electric and Power Raises USD400 Million in Public Offering of Series B 2.95% Notes Due 2026 36
Virginia Electric and Power Raises USD500 Million in Public Offering of Series C 4% Notes Due 2046 38
Virginia Electric and Power Raises USD750 Million in Public Offering of 3.15% Notes Due 2026 for USD750 Million 40
Virginia Electric and Power Raises USD350 Million in Public Offering of 3.1% Notes Due 2025 42
Virginia Electric and Power Raises USD350 Million in Public Offering of 4.2% Notes Due 2045 44
Virginia Electric and Power Completes Public Offering Of 3.45% Notes Due 2024 For US$350 Million 46
Virginia Electric and Power Completes Public Offering Of 4.45% Notes Due 2044 For US$400 Million 48
Virginia Electric and Power Completes Public Offering Of Notes Due 2043 For US$585 Million 50
Virginia Electric and Power Completes Public Offering Of 2.75% Notes Due 2023 For US$500 Million 52
Virginia Electric and Power Completes Public Offering Of 1.2% Notes Due 2018 For US$250 Million 53
Virginia Electric and Power Completes Public Offering Of 4% Notes Due 2043 For US$500 Million 54
Virginia Electric and Power Completes Public Offering Of 2.95% Senior Notes Due 2022 For US$450 Million 55

★海外企業調査レポート[Virginia Electric and Power Company：企業の発電所・SWOT分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Viking Therapeutics Inc (VKTX)：企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • Yakult Honsha Co Ltd (2267)：企業の財務・戦略的SWOT分析
    Yakult Honsha Co Ltd (2267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Commonwealth Bank of Australia：戦略・SWOT・企業財務分析
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xencor Inc (XNCR)：企業の財務・戦略的SWOT分析
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company. It develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the t …
  • Repsol SA (REP)：企業の財務・戦略的SWOT分析
    Repsol SA (REP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Recro Pharma Inc (REPH)：企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Big 5 Sporting Goods Corporation：企業の戦略・SWOT・財務情報
    Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Precipio Inc (TBIO)：企業の財務・戦略的SWOT分析
    Summary Precipio Inc (Precipio), formerly known as Transgenomic Inc, develops diagnostic tools. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. Precipio uses ICE COLD-P …
  • Slovnaft AS (1SLN01AE)：企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • A. Menarini Industrie Farmaceutiche Riunite Srl：企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Ironwood Pharmaceuticals Inc (IRWD)-製薬・医療分野：企業M&A・提携分析
    Summary Ironwood Pharmaceuticals Inc (Ironwood) is a commercial biotechnology company that discovers, develops and commercializes medicines for gastrointestinal (GI) disorders. The company's marketed products consist of Linzess (linaclotide), an oral capsule for the treatment of irritable bowel synd …
  • Cardinal Ethanol LLC (CRDE)：企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Leprino Foods Co：企業の戦略的SWOT分析
    Leprino Foods Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • WNDM Medical Inc (WNDM)：製薬・医療：M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Genalyte Inc：医療機器：M&Aディール及び事業提携情報
    Summary Genalyte Inc (Genalyte) is a lab testing service provider. The company’s services include data analysis, phlebotomist for blood draw, integration with existing emr, phlebotomist for blood draw, applications for test order and results review and clinical lab scientist. It provides instruments …
  • Avid Bioservices Inc (CDMO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Avid Bioservices Inc (Avid Bioservices), formerly Peregrine Pharmaceuticals Inc, is a biopharmaceutical company that develops, manufactures and markets monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituxi …
  • Intas Pharmaceuticals Ltd：企業の戦略的SWOT分析
    Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • LivaNova PLC (LIVN)-医療機器分野：企業M&A・提携分析
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by trea …
  • SQI Diagnostics Inc (SQD)：企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. I …
  • BELLUS Health Inc (BLU)：製薬・医療：M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆